As per the recently published report by MarketsandMarkets™, The report "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) - Global Forecast to 2029", is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Browse
- 150
Market Data Tables
- 65
Figures
- 350
Pages and in-depth TOC on " Hemodialysis and Peritoneal Dialysis
Market - Global Forecast to 2029”
Some of the prominent key players are:
- Fresenius
Medical Care AG & Co. KGaA (Germany),
- Baxter
International Inc. (US),
- Nipro
Corporation (Japan),
- NIKKISO
CO., LTD. (Japan), and many more......
Mergers
& acquisitions, investments & expansions, partnerships &
collaborations, and new product developments are some of the major strategies
adopted by these key players to enhance their positions in the Hemodialysis and
Peritoneal Dialysis Market .
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279
- The
hemodialysis market is segmented based on product and service.
Hemodialysis products include hemodialysis machines and hemodialysis
consumables & supplies, whereas hemodialysis services include in-center
services and home services. The hemodialysis services segment is
anticipated to grow at significant rate during the forecast period.
- Based
on end users, home care setting is expected to grow at a significant rate
owing to growing preference of patients for home hemodialysis modality,
technological advancements, and the cost-effectiveness of home dialysis
treatment over incentre dialysis procedures.
- On the
basis of region, the hemodialysis and peritoneal dialysis market is
segmented into North America, Europe, Asia Pacific, and the Latin America,
Middle East & Africa. The Asia-Pacific market is likely to witness
significant market growth. This is attributed to the rise in geriatric
patient population, increasing cases of chronic kidney diseases, moreover
improving healthcare infrastructure and the implementation of supportive
government initiatives to increase the accessibility of dialysis services
in many APAC countries such as India and China.
The escalating global
prevalence of chronic kidney disease, spurred by growing aging population
coupled with the increasing cases of diabetes and hypertension are fuelling the
demand for renal replacement therapy including hemodialysis and peritoneal dialysis
products and services. Ongoing technological advancements in dialysis
technology, growing patient preference of home dialysis, supporting
reimbursement policies and government initiatives and funding for healthcare
infrastructure, enabling expansion of hospitals and dialysis centers further
enhancing the accessibility of hemodialysis and peritoneal dialysis services
among patients with end-stage renal disease (ESRD) are likely to drive the
market growth during the forecast period.
No comments:
Post a Comment